Artur Wilhelm

Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus

A. Ekici, A. Mackensen, D. Mougiakakos, 2022, Nature Medicine.

Author Correction: Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus

A. Ekici, A. Mackensen, D. Mougiakakos, 2022, Nature Network Boston.

CD19-Targeted CAR-T Cells in Refractory Systemic Autoimmune Diseases: A Monocentric Experience from the First Fifteen Patients

M. Aigner, Simon Voelkl, T. Rothe, 2023, Blood.

CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up.

M. Aigner, A. Korganow, A. Bozec, 2024, The New England journal of medicine.

Bispecific T cell engager therapy for refractory rheumatoid arthritis.

A. Bozec, S. Alivernini, T. Rothe, 2024, Nature medicine.

Selective CAR-T cell mediated B cell depletion suppresses interferon signature in SLE.

A. Bozec, Artur Wilhelm, Andreas Mackensen, 2024, JCI insight.

CAR-T Cell Therapy in Patients with Refractory Systemic Autoimmune Diseases Exhibits Less Inflammation, Toxicities and Different Cellular Dynamics Compared to Patients with B Cell Lymphoma

M. Aigner, H. Bruns, Simon Voelkl, 2023, Blood.